UY29161A1 - Nuevos heterociclos - Google Patents

Nuevos heterociclos

Info

Publication number
UY29161A1
UY29161A1 UY29161A UY29161A UY29161A1 UY 29161 A1 UY29161 A1 UY 29161A1 UY 29161 A UY29161 A UY 29161A UY 29161 A UY29161 A UY 29161A UY 29161 A1 UY29161 A1 UY 29161A1
Authority
UY
Uruguay
Prior art keywords
new
heterociclos
cancer
methods
compounds
Prior art date
Application number
UY29161A
Other languages
English (en)
Inventor
Chengzhi Zhang
Dongping Fan
Yingfu Li
Roger Smith
Jacques Dumas
Jason Duquette
Qian Zhao
Goergiy Bondar
Original Assignee
Bayer Pharmaceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharmaceuticals Corp filed Critical Bayer Pharmaceuticals Corp
Publication of UY29161A1 publication Critical patent/UY29161A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

Esta invención se refiere a nuevos compuestos y procesos para su preparación, métodos para tratar enfermedades, especialmente enfermedades hiperproliferativas tales como cáncer, que comprende administrar dichos compuestos, y métodos para fabricar composiciones farmaceúticas para el tratamiento o prevención de desórdenes, especialmente enfermedades hiperproliferativas tales como cáncer.
UY29161A 2004-10-15 2005-10-13 Nuevos heterociclos UY29161A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61906604P 2004-10-15 2004-10-15

Publications (1)

Publication Number Publication Date
UY29161A1 true UY29161A1 (es) 2006-04-28

Family

ID=35759133

Family Applications (1)

Application Number Title Priority Date Filing Date
UY29161A UY29161A1 (es) 2004-10-15 2005-10-13 Nuevos heterociclos

Country Status (12)

Country Link
US (1) US7750017B2 (es)
EP (1) EP1802633B1 (es)
JP (1) JP5070058B2 (es)
AR (1) AR052019A1 (es)
AT (1) ATE518867T1 (es)
CA (1) CA2584303A1 (es)
ES (1) ES2369235T3 (es)
GT (1) GT200500291A (es)
PE (1) PE20060976A1 (es)
TW (1) TW200628473A (es)
UY (1) UY29161A1 (es)
WO (1) WO2006044524A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7960400B2 (en) 2007-08-27 2011-06-14 Duquesne University Of The Holy Ghost Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereof
US7982035B2 (en) 2007-08-27 2011-07-19 Duquesne University Of The Holy Spirit Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof
US8802849B2 (en) 2008-02-19 2014-08-12 Vichem Chemie Kutató Kft. Tricyclic benzo[4,5]thieno-[2,3-d]pyrimidine-4-yl-amin derivatives, their salts, process for producing the compounds and their pharmaceutical use
AP2975A (en) 2008-07-16 2014-09-30 Richter Gedeon Nyrt Pharmaceutical formulations containing dopamine receptor ligands
US9085586B2 (en) * 2012-07-11 2015-07-21 Nimbus Iris, Inc. IRAK inhibitors and uses thereof
WO2014118229A1 (en) * 2013-02-01 2014-08-07 Bayer Pharma Aktiengesellschaft Substituted thienopyrimidines and pharmaceutical use thereof
TW201605867A (zh) * 2013-11-20 2016-02-16 拜耳製藥公司 噻吩并嘧啶
US11274087B2 (en) 2016-07-08 2022-03-15 Richter Gedeon Nyrt. Industrial process for the preparation of cariprazine
HU231173B1 (hu) 2016-07-08 2021-06-28 Richter Gedeon Nyrt. Ipari eljárás cariprazine előállítására
TWI813611B (zh) 2017-12-21 2023-09-01 美商律幫治療股份有限公司 作為parp14抑制劑之喹唑啉酮
CN108285421A (zh) * 2018-01-26 2018-07-17 黑龙江鑫创生物科技开发有限公司 一种微通道反应器合成拉帕替尼中间体的方法
CN108456184B (zh) * 2018-03-28 2020-02-07 南方医科大学 一种靶向egfr与eps8结合的小分子抑制剂及其应用
US11547707B2 (en) 2019-04-10 2023-01-10 Richter Gedeon Nyrt. Carbamoyl cyclohexane derivatives for treating autism spectrum disorder
CN110818618A (zh) * 2019-11-26 2020-02-21 山东铂源药业有限公司 一种吡咯替尼中间体2-[(2-氯-4-硝基苯氧基)甲基]吡啶的合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5679683A (en) 1994-01-25 1997-10-21 Warner-Lambert Company Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
GB9520822D0 (en) 1995-10-11 1995-12-13 Wellcome Found Therapeutically active compounds
DE69710712T3 (de) * 1996-04-12 2010-12-23 Warner-Lambert Co. Llc Umkehrbare inhibitoren von tyrosin kinasen

Also Published As

Publication number Publication date
ES2369235T3 (es) 2011-11-28
JP2008516963A (ja) 2008-05-22
WO2006044524A1 (en) 2006-04-27
CA2584303A1 (en) 2006-04-27
PE20060976A1 (es) 2006-10-20
TW200628473A (en) 2006-08-16
JP5070058B2 (ja) 2012-11-07
ATE518867T1 (de) 2011-08-15
US7750017B2 (en) 2010-07-06
US20080132497A1 (en) 2008-06-05
EP1802633A1 (en) 2007-07-04
GT200500291A (es) 2006-10-10
AR052019A1 (es) 2007-02-28
EP1802633B1 (en) 2011-08-03

Similar Documents

Publication Publication Date Title
UY29161A1 (es) Nuevos heterociclos
DOP2007000053A (es) Compuestos de tetrahidropiridotienopirimidina y métodos para su empleo
WO2007068894A3 (en) Substituted diphenylethers, -amines, -sulfides and -methanes for the treatment of respiratory disease
ECSP10010042A (es) Compuestos y composiciones como moduladores de la actividad de gpr119
CR9347A (es) Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos
WO2006058868A8 (de) Substituierte pteridine zur behandlung von entzündlichen erkrankungen
WO2007064932A3 (en) Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase
AR063628A1 (es) Compuestos de piridinona utiles para el tratamiento de cancer
EA200901032A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
EA201690265A2 (ru) Фармацевтические композиции, содержащие замещенные ациланилиды
BRPI0610090A2 (pt) terapia de combinaÇço compreendendo diaril urÉias para tratar doenÇas
UA103930C2 (ru) Соединения и композиция для лечения паразитарных болезней
DOP2005000025A (es) Compuestos de heteroaril- y fenilsulfamoilo sustituidos
UY29079A1 (es) Acidos fenoxiacéticos sustituidos, composiciones que los contienen, procedimientos de preparación y aplicaciones
WO2006058869A8 (de) Substituierte pteridine zur behandlung von entzündlichen erkrankungen
MX2010003269A (es) Derivados de pirrolotriazina utiles para tratar cancer a traves de la inhibicion de la aurora quinasa.
MX2011008899A (es) Nuevas orto-aminoamidas para el tratamiento del cancer.
BRPI0606322A2 (pt) formulações intravenosas de inibidores de pde-5
WO2007135026A3 (de) Substituierte pteridine als therapeutika
WO2010121164A3 (en) 1,4-benzodiazepinone compounds and their use in treating cancer
TW200633711A (en) Substituted pteridines for the treatment of inflammatory diseases
GT200500070A (es) Compuestos de sulfonamidas para el tratamiento de trastornos neurodegenerativos
EA201001085A1 (ru) Фармацевтические композиции, содержащие гранулы очищенной микробной липазы, и способы предупреждения или лечения пищеварительных нарушений
EA201101579A1 (ru) Имидазо[1,2-а]пиридин-2-ил-фенил производные для лечения рака
EA200702336A1 (ru) ПРИМЕНЕНИЕ 24-норУДХК

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20160607